You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Deployable Closed-Loop Anesthesia System
SBC: NEUROWAVE SYSTEMS INC Topic: OSD10H05The AutoTIVA system, to be developed under this program, comes as an answer to the Army requirement for a "deployable automated analgesia and anesthesia system".The AutoTIVA device concept is akin to that of an autopilot for anesthesia and sedation, where the administration of both intravenous analgesics and hypnotics are adjusted continuously in real-time, to drive and maintain patients in a pre- ...
SBIR Phase II 2012 Department of DefenseDefense Health Agency -
Real-Time Small-Volume Blood Sampling and Analysis for Coagulopathy of Trauma Analytes
SBC: APTITUDE MEDICAL SYSTEMS INC Topic: DHP15012Traumatic hemorrhage is the primary mechanism of death in potentially survivable combat injuries, and is the leading cause of death for civilians under the age of 44. A major underlying cause of this high mortality is Acute Traumatic Coagulopathy, a deadl
SBIR Phase II 2020 Department of DefenseDefense Health Agency -
Development for ShockDefender against Hemorrhagic Shock
SBC: ZYMERON CORP Topic: DHA234D001Hemorrhagic shock is responsible for over 35% of prehospital traumatic deaths and over 40% of all deaths within the first 24 hours following injury. Multiple intervention strategies are necessary for prolonged prehospital management and improved casualty survivability including improved blood products, hemostatics, damage control resuscitation, as well as therapeutic interventions targeting coagul ...
SBIR Phase II 2023 Department of DefenseDefense Health Agency -
Novel Biologic Countermeasure for Acute Radiation Syndrome
SBC: Technology Holding, LLC Topic: DHA201002Acute Radiation Syndrome (ARS) is an acute illness caused by irradiation of a significant portion of the body by a high dose of ionizing radiation (IR) in a short period of time. Global proliferation of radioactive and nuclear materials has resulted in increased threat of weaponized exposure or inadvertent exposure resulting from industrial accidents such as the case with the Chernobyl Nuclear Pow ...
SBIR Phase II 2022 Department of DefenseDefense Health Agency -
Development for a novel countermeasure, RadioDefender, as a radioprotector for hematopoietic acute radiation syndrome
SBC: ZYMERON CORP Topic: DHA201002Acute radiation syndrome (ARS) is a severe illness that occurs when a person is exposed to high levels of ionizing radiation, typically within a relatively short period. The hematopoietic system is most vulnerable for radiation exposure since mild symptoms may occur at the exposure dose of as low as 0.3 Gy, and severe ionizing radiation-induced hematopoietic failure usually results in lethal infec ...
SBIR Phase II 2022 Department of DefenseDefense Health Agency -
Oxygen Production on Demand for Military Medical Needs
SBC: GLOBAL RESEARCH & DEVELOPMENT INC Topic: DHA17B005Topic 17B-005 calls for a new process for supplying medical grade O2 without the use of O2 bottles or pressure (or vacuum) swing absorption (PSA) technology. This is significant to the military for several reasons, because these two sources currently interfere with logistical supply of O2 to where it is required, namely field hospital units. PSA units reportedly have limited shelf life and supply ...
STTR Phase II 2021 Department of DefenseDefense Health Agency -
IND-enabling Studies of PM-208: A Novel Pre-hospital Anti-Shock Therapeutic
SBC: PERFUSION MEDICAL LLC Topic: DHA234D001The direct and indirect effects of severe and prolonged tissue hypoxia due to hemorrhagic shock are leading causes of death following battlefield injuries. About 20% of all battlefield deaths are potentially survivable. Of these, most service members (84%) suffered hemorrhage and potentially could have been saved. Resuscitation in the field is often seriously inadequate even in patients transpor ...
SBIR Phase II 2023 Department of DefenseDefense Health Agency -
Mobile Applications/Web-Based Management Solutions for Hearing Injuries
SBC: CREARE LLC Topic: DHP14008Hearing loss and tinnitus remain the most common service-connected disabilities, and may be caused by excessive noise exposure, as well as blast and impulse noise.Soldiers who experience tinnitus or mild-to-moderate hearing loss tend to have difficulty understanding speech-in-noise.While peripheral hearing loss can be addressed with amplification through a hearing aid, significant rehabilitation i ...
SBIR Phase II 2016 Department of DefenseDefense Health Agency -
High Bandwidth Redundant Communication Links for Small Satellites
SBC: Innoflight, Inc. Topic: A16079Innoflight will develop a high performance software-defined compact radio (SCR) with Ka and X dual band downlink capability and S Band uplink capability. The Ka / X SCR will support 300 Mbps downlink and 5 Mbps uplinks rates using advanced spectrally efficient waveforms. It will offer interoperability with standard government and commercial ground stations such as the Army RGT (Remote Ground Termi ...
SBIR Phase II 2019 Department of DefenseDefense Health Agency -
Donaldson Decompression Needle for automated diagnosis and treatment of tension pneumothorax
SBC: CRITICAL INNOVATIONS LLC Topic: DHA191007The purpose of this SBIR topic is to develop a device for automating needle decompression to more effectively manage tension pneumothorax on the battlefield.
SBIR Phase II 2022 Department of DefenseDefense Health Agency